Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1995;13(4):277-83.
A workshop for collaborative study on circulating Schistosoma japonicum antigen detection was held at the Hunan Institute of Parasitic Diseases, Yueyang, Hunan Province in May, 1993. Eight laboratories from schistosomiasis-endemic provinces (municipalities) were joined in this study. Scientists from these laboratories performed serological assays in blind using their own brought test systems that developed during recent years. The serum samples tested covered 100 non-endemic controls, 190 from patients with active schistosomiasis, 110 from cured cases of schistosome-infection, and 170 from individuals harbouring other parasitic infections or hepatitis. Results of the study revealed an assay specificity, in terms of false positive rate, of 2% in Series B versus 14-46% in the other 7 series. With regard to assay sensitivity, all test series showed 95-100% for acute cases. While for chronic cases, test series A and F demonstrated sensitivities at 73.3% and 72.7% respectively. Other series were all below 70%. Negative reversion rates for sera from cured cases within 1 year post-treatment were below 33.3%, those within 2 years were 60% for Series E, while below 50% for all others except the Series H which was excluded due to an extremely low sensitivity obtained. The low values of these test series for chemotherapy assessment may be attributed to the poor specificity of the detecting systems used and/or the sample donors being not totally cured. It is strongly indicated that all the 8 test systems involved in the present study should further be improved in sensitivity, specificity as well as in capacity for pre-and post-treatment evaluations.
1993年5月,血吸虫循环抗原检测协作研究讲习班在湖南省岳阳市的湖南省寄生虫病研究所举行。来自血吸虫病流行省份(直辖市)的8个实验室参与了这项研究。这些实验室的科学家们使用他们近年来开发的自带检测系统进行了盲法血清学检测。检测的血清样本包括100份非流行对照、190份急性血吸虫病患者样本、110份血吸虫感染治愈病例样本以及170份感染其他寄生虫或患有肝炎的个体样本。研究结果显示,B系列检测的假阳性率所代表的检测特异性为2%,而其他7个系列的假阳性率为14% - 46%。在检测灵敏度方面,所有检测系列对急性病例的灵敏度均为95% - 100%。对于慢性病例,A系列和F系列的灵敏度分别为73.3%和72.7%。其他系列均低于70%。治疗后1年内治愈病例血清的阴性转化率低于33.3%,2年内E系列为60%,除因灵敏度极低而被排除的H系列外,其他系列均低于50%。这些检测系列用于化疗评估的低值可能归因于所用检测系统的特异性差和/或样本捐赠者未完全治愈。强烈表明,本研究中涉及的所有8种检测系统应在灵敏度、特异性以及治疗前后评估能力方面进一步改进。